{"name":"Vera Bril","slug":"vera-bril","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMinAJBVV95cUxON0tXTUpKZU9OLXNTM25TNkFtOUdSdTR0Y0Rjd01LbHQ3VExTZW5GV3EtaWhuakpNbDhQYlJUQ2pUbUlwSEV4TUswVFNfeUp0UEVVVnFHX2ZLd3l0UVh6UTBNZUcyRklxWUMyM0N4R29WYUxCU3F5TGpZSU1zbkR5VzZqbWNwODZkTU1TbFhjay1LQUV3WFN3cVNsNE9FODJBanRzb0RzeTNYeXZwTUpfa29kV3lMVTlsLXFxbDMwOEF5cjYzZm1iRW9ZbG82dmNWd3BkdTFQLVFFTHQ5VVo2WmxGVnVrblpYMGVQdHJEaTlmSWU1VTRtWXFUTkdQbE4tSlpqSmVQc0tRTVdHZG1iYXlaVUJRVTZOMHpMNg?oc=5","date":"2025-03-27","type":"pipeline","source":"Newswire Canada","summary":"Takeda's HyQvia® receives expanded market authorization as maintenance therapy for chronic inflammatory demyelinating polyneuropathy (CIDP) - Newswire Canada","headline":"Takeda's HyQvia® receives expanded market authorization as maintenance therapy for chronic inflammatory demyelinating po","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirgFBVV95cUxPdzJtSXhBMjh5NjdBaHI3T0dRYmVucTZCY0pxSHNjbjIyWHpYZ3ZPLXRRTFpLUHRZNWdOaTVyUXJlaklNVkRmUEEwRi1yS0Voam5qRkx5ZXlhYXlBTlBvSnpycFpJM214bk8yOG83bTJXUGNwbVhsbmY3cjI2QzZadnQ0R1U5MG9xaG5UUTVaa1ZyaFZwY1JyeTk4UTMwanVZSFBCMWJ0eVRXTnRpU0E?oc=5","date":"2023-06-27","type":"regulatory","source":"Fierce Pharma","summary":"UCB finally gets a win with the FDA, scoring approval for myasthenia gravis drug Rystiggo - Fierce Pharma","headline":"UCB finally gets a win with the FDA, scoring approval for myasthenia gravis drug Rystiggo","sentiment":"positive"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}